We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDY icon
2026
PUT
monday.com
MNDY
$3.7B
$15.8M ﹤0.01%
153,000
+3,100
+2% +$377K
CBOE icon
2027
PUT
Cboe Global Markets
CBOE
$30.9B
$15.8M ﹤0.01%
139,400
+36,200
+35% +$4.06M
NWSA icon
2028
News Corp Class A
NWSA
$15.8B
$15.8M ﹤0.01%
1,012,275
-2,758,165
-73% -$50.7M
KMI icon
2029
Kinder Morgan
KMI
$73.1B
$15.8M ﹤0.01%
940,731
-524,109
-36% -$9.81M
MP icon
2030
PUT
MP Materials
MP
$10.5B
$15.8M ﹤0.01%
491,000
+204,700
+71% +$8.26M
PNT
2031
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$15.7M ﹤0.01%
2,310,177
-182,986
-7% -$1.4M
HOG icon
2032
CALL
Harley-Davidson
HOG
$2.89B
$15.7M ﹤0.01%
496,400
+63,400
+15% +$2.25M
ACGL icon
2033
Arch Capital
ACGL
$33.7B
$15.7M ﹤0.01%
345,225
+211,486
+158% +$9.8M
VSTO
2034
DELISTED
Vista Outdoor Inc.
VSTO
$15.7M ﹤0.01%
562,449
-61,438
-10% -$2.19M
TDAY
2035
CALL
USA Today Co
TDAY
$1.03B
$15.7M ﹤0.01%
5,403,600
-140,300
-3% -$534K
SHLS icon
2036
Shoals Technologies Group
SHLS
$1.42B
$15.7M ﹤0.01%
950,228
+410,572
+76% +$6.06M
FRO icon
2037
Frontline
FRO
$9.17B
$15.6M ﹤0.01%
1,765,495
+910,391
+106% +$8.24M
LGIH icon
2038
LGI Homes
LGIH
$1.39B
$15.6M ﹤0.01%
179,970
+148,470
+471% +$13.8M
HASI icon
2039
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
$15.6M ﹤0.01%
413,026
-273,896
-40% -$10.9M
STLA icon
2040
PUT
Stellantis
STLA
$20.2B
$15.6M ﹤0.01%
1,264,000
-172,100
-12% -$2.43M
TROX icon
2041
Tronox
TROX
$952M
$15.6M ﹤0.01%
928,786
+901,254
+3,273% +$16.3M
APTV icon
2042
PUT
Aptiv
APTV
$10.3B
$15.6M ﹤0.01%
174,800
-86,600
-33% -$8.84M
LPX icon
2043
Louisiana-Pacific
LPX
$5.17B
$15.5M ﹤0.01%
296,356
-432,475
-59% -$27.7M
PCAR icon
2044
PACCAR
PCAR
$68.8B
$15.5M ﹤0.01%
282,815
-931,408
-77% -$52.5M
OSH
2045
DELISTED
Oak Street Health, Inc.
OSH
$15.5M ﹤0.01%
944,066
+110,153
+13% +$2.14M
RS icon
2046
CALL
Reliance Steel & Aluminium
RS
$21.8B
$15.5M ﹤0.01%
91,300
+51,500
+129% +$9.62M
UVXY icon
2047
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$273M
$15.5M ﹤0.01%
4,265
-496
-10% -$1.86M
VOD icon
2048
PUT
Vodafone
VOD
$37.9B
$15.5M ﹤0.01%
993,800
+55,800
+6% +$891K
DGX icon
2049
PUT
Quest Diagnostics
DGX
$25.9B
$15.5M ﹤0.01%
116,400
+15,600
+15% +$2.13M
MMM icon
2050
3M
MMM
$94.2B
$15.5M ﹤0.01%
142,862
-43,771
-23% -$5.29M

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.